Citations

Showing 10 of 108152 citations.

Clinical characteristics and outcomes of mild to moderate alcoholic hepatitis
Samala, Niharika , Tang, Qing , Lourens, Spencer, Shah, Vijay H. , Sanyal, Arun J. , Liangpunsakul, Suthat , Chalasani, Naga , Sanyal, A J , Chalasani, Naga , Gawrieh, Samer

Mayo Clinic

GastroHep | June 14, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/ygh2.353 | PMID 32952446 Get It

Immune checkpoint inhibitor‐induced Type 1 diabetes: a systematic review and meta‐analysis
Aktürk, Halis Kaan , Kahramangil, Doga , Sarwal, Amara , Murad, M. Hassan , Michels, Aaron W. , Akturk, Halis K , Michels, A W , Murad, M Hassan , Hoffecker, Lilian

Mayo Clinic

Diabetic Medicine | June 14, 2019 | Volume: 36 | Issue: 9 | Pages: 1075-1081

10.1111/dme.14050 | PMID 31199005 Get It

Aim To conduct a systematic review and meta‐analysis to understand the timing and factors associated with anti‐programmed cell death protein‐1 ( PD ‐1)/anti‐programmed cell death protein‐1 ligand ( PD ‐L1) inhibitor‐induced Type 1 diabetes. Methods We searched MEDLINE , EMBASE , SCOPUS and Cochrane databases (August 2000–2018) for studies of any design on immune checkpoint inhibitors. A total of 71 cases were reviewed from 56 publications. Comparisons were made using Fisher's exact and Student's t ‐tests. Results The mean ± sd age at Type 1 diabetes presentation was 61.7±12.2 years, 55% of cases were in men, and melanoma (53.5%) was the most frequent cancer. The median time to Type 1 diabetes onset was 49 (5–448) days with ketoacidosis in 76% of cases. The average ± sd HbA 1c concentration was 62 ± 0.3 mmol/mol (7.84±1.0%) at presentation. All cases had insulin deficiency and required permanent exogenous insulin treatment. Half of the cases had Type 1 diabetes‐associated antibodies at presentation, and those with antibodies had a more rapid onset ( P =0.005) and higher incidence of diabetic ketoacidosis ( P =0.02) compared to people without antibodies. Conclusions Many people developed Type 1 diabetes within 3 months of initial PD ‐1/ PD ‐L1 inhibitor exposure. People presenting with Type 1 diabetes‐associated antibodies had a more rapid onset and higher incidence of ketoacidosis than those without antibodies. Healthcare providers caring for people receiving these state‐of‐the‐art therapies need to be aware of this potential severe adverse event.
Coronary Artery Disease in Adults With Coarctation of Aorta: Incidence, Risk Factors, and Outcomes
Egbe, Alexander C. , Rihal, Charanjit S. , Thomas, Alexa , Boler, Amber, Mehra, Nandini , Andersen, Kylie J. , Kothapalli, Srikanth, Taggart, Nathaniel W. , Connolly, Heidi M. , Andersen, Kylie, Taggart, Nathaniel W , Andersen, Kylie , Thomas, Alexa L , Rihal, Charanjit S.

Mayo Clinic

Journal of the American Heart Association | June 14, 2019 | Volume: 8 | Issue: 12 | Pages: No page available

10.1161/jaha.119.012056 | PMID 31195876 Get It

Background Premature coronary artery disease ( CAD ) is common in patients with coarctation of aorta ( COA ), but there are limited data about any direct relationship (or lack thereof) between COA and CAD . We hypothesized that atherosclerotic cardiovascular disease risk factors, rather than COA diagnosis, was the primary determinant of CAD occurrence in patients with COA . Methods and Results This is a retrospective study of 654 COA patients and a control group of 876 patients with valvular pulmonic stenosis and tetralogy of Fallot to determine prevalence and independent risk factors for CAD . There was no evidence of a difference in the unadjusted CAD prevalence between the COA and control groups (7.8% versus 6.3%, P =0.247), but premature CAD was more common in COA patients (4.4% versus 1.8%, P =0.002). In the analysis of a propensity‐matched cohort of 126 COA and 126 control patients, there was no evidence of a difference in overall CAD prevalence (6.3% versus 5.6% versus P =0.742) and premature CAD prevalence (4.8% versus 3.2%, P =0.518). The multivariable risk factors for CAD were hypertension (odds ratio [ OR ] 2.14; 95% CI 1.36–3.38), hyperlipidemia ( OR 3.33; 95% CI 2.02–5.47), diabetes mellitus ( OR 1.98; 95% CI 1.31–3.61), male sex ( OR 2.05; 95% CI 1.33–3.17), and older age per year ( OR 1.06; 95% CI 1.04–1.07). Conclusions After adjusting for atherosclerotic cardiovascular disease risk factors, we did not find evidence of a difference in CAD risk between the patients with COA and other patients with congenital heart disease.
Radial Versus Femoral Access in Chronic Total Occlusion Percutaneous Coronary Intervention
Karatasakis, Aris , Abraham, Bishoy , Jensen, Joseph , Omer, Mohamed , Elbadawi, Ayman , Sandoval, Yader , Shishehbor, Mehdi H. , Rinfret, Stéphane , Megaly, Michael S. , Saad, Marwan , Banerjee, Subhash , Alaswad, Khaldoon , Burke, M. Nicholas , Brilakis, Emmanouil S.

Mayo Clinic

Circulation: Cardiovascular Interventions | June 14, 2019 | Volume: 12 | Issue: 6 | Pages: No page available

10.1161/circinterventions.118.007778 | PMID 31195826 Get It

Background: Radial access (RA) is increasingly used in chronic total occlusion (CTO) percutaneous coronary intervention with encouraging results. However, there are concerns about its safety and efficacy because of higher complexity and the need for strong guide catheter support. Methods and Results: We performed a systematic review and meta-analysis of all studies published through November 2018 reporting the outcomes of RA versus femoral access in CTO percutaneous coronary intervention. Outcomes included major bleeding, access-site complications, in-hospital major adverse events, and technical success. Nine observational studies with 10 590 patients (10 617 lesions) were included in the meta-analysis. CTO lesions attempted using RA had lower Japan-CTO score (2.3±1.2 versus 2.5±1.3; P <0.001). Use of RA was associated with similar technical success (78.7% versus 78.5%; odds ratio, 1.11; 95% CI, 0.94–1.31; P =0.24; I 2 =23%), lower risk of access-site complications (0.73% versus 1.79%; odds ratio, 0.34; 95% CI, 0.22–0.51; P <0.001; I 2 =0%) and major bleeding (0.18% versus 0.9%; odds ratio, 0.22; 95% CI, 0.10–0.45; P <0.001; I 2 =0%), and similar risk of in-hospital adverse events and in-hospital mortality (odds ratio, 0.36; 95% CI, 0.12–1.07; P =0.07; I 2 =0%) as compared to femoral access. Results were similar when analyzing radial-only versus any femoral access and when excluding the largest study. Conclusions: As compared with femoral access, RA is used in CTO percutaneous coronary intervention of less complex lesions and is associated with fewer access-site complications and major bleeding and comparable technical success.
Outcomes of Pregnancy in Patients With Prior Right Ventricular Outflow Interventions
Egbe, Alexander C. , El‐Harasis, Majd , Miranda, William R. , Ammash, Naser M., Rose, Carl H., Fatola, Ayotola , Kothapalli, Srikanth, Abdelsamid, Mohamed Farouk, Connolly, Heidi M.

Mayo Clinic

Journal of the American Heart Association | June 14, 2019 | Volume: 8 | Issue: 12 | Pages: No page available

10.1161/jaha.118.011730 | PMID 31195875 Get It

Background The purpose of this study was to compare the incidence of pregnancy‐related adverse outcomes ( PRAO ) between patients with versus without hemodynamically significant right ventricle outflow tract ( RVOT) . Methods and Results This was a retrospective cohort study of all pregnant patients with isolated RVOT lesions undergoing evaluation at the Mayo Clinic, 1990 to 2017. Hemodynamic significance was defined as ≥moderate pulmonary/conduit stenosis (≥3 m/s) and/or ≥moderate regurgitation. Patients with concomitant significant left heart disease were excluded. PRAO was defined as cardiovascular, obstetric, and/or neonatal complications occurring during the pregnancy through 6 weeks postpartum. A total of 224 pregnancies in 114 patients with RVOT lesions were identified; 38 pregnancies occurred in 24 patients with hemodynamically significant RVOT . Forty‐eight (21%) pregnancies ended in spontaneous abortion. Of the 173 completed pregnancies, median gestational age at delivery was 38 (35–40) weeks and median birth weight 2965 (2065–4122) g. Seven pregnancies (4%) were complicated by cardiovascular events, 14 (8%) by obstetric complications, with adverse neonatal outcomes occurring in 38 (22%). There were no maternal deaths. The incidence of spontaneous abortion and PRAO were similar in both the RVOT and hemodynamically significant RVOT groups. As an isolated condition, Tetralogy of Fallot–pulmonary atresia was associated with spontaneous abortion and neonatal complications. Conclusions The risk of cardiovascular complications was low in patients with isolated RVOT lesions, and hemodynamically significant RVOT lesions were not associated with either cardiovascular complications or PRAO . Further studies are required to explore the factors responsible for PRAO in patients with Tetralogy of Fallot–pulmonary atresia.
Quantitative Assessment of Trace‐Element Contamination in Parenteral Nutrition Components
Olson, Logan M. , Wieruszewski, Patrick M. , Jannetto, Paul J. , Abbott, Jillian C., McMahon, M. Molly , Nystrom, Erin M., Wieruszewski, Patrick M

Mayo Clinic

Journal of Parenteral and Enteral Nutrition | June 14, 2019 | Volume: 43 | Issue: 8 | Pages: 970-976

10.1002/jpen.1668 | PMID 31197862 Get It

AbstractBackgroundTrace‐element contamination of contemporary parenteral nutrition (PN) components exists in unknown quantities and, in combination with excessive amounts of certain trace elements provided in commercially available adult, pediatric, and neonatal multitrace‐element (MTE) products, could result in eventual accumulation and toxicity. This study aims to quantify trace‐element contamination in components used for PN compounding to further inform recommendations for MTE product reformulation and individualized trace‐element prescribing in PN.MethodsA total of 32 unique components (65 products) available for PN compounding were tested for manganese, chromium, selenium, zinc, and copper contamination, utilizing inductively coupled plasma mass spectrometry. Theoretical adult, pediatric, and neonatal PNs were formulated to assess the impact of macronutrient and micronutrient component doses on PN trace‐element contamination.ResultsTrace‐element contamination was detected in 24 (75%) components tested. Chromium and manganese were common, present in 65.6% and 51.5% of all components, respectively. Eight components did not contain detectable trace‐element contamination, most notably sterile water, concentrated dextrose, and lipid emulsion. Manganese contamination in theoretical adult, pediatric, and neonatal PN was 25.18, 9.92, and 1.37 µg, respectively. Chromium contamination was 4.85, 1.5, and 0.28 µg, respectively.ConclusionTrace‐element contamination was prevalent in components used to compound PN. Our findings support reformulation of adult, pediatric, and neonatal manufactured MTE products to eliminate chromium, decrease manganese, and supply full daily physiologic requirements of selenium, zinc, and copper. Future study is needed to assess the additional contamination that could occur through the compounding and storage processes.
Case Studies in Physiology: Temporal changes in determinants of aerobic performance in individual going from alpine skier to world junior champion time trial cyclist
Rønnestad, Bent R. , Hansen, Joar, Stensløkken, Lars, Lundby, Carsten , Joyner, Michael J.

Mayo Clinic

Journal of Applied Physiology | June 13, 2019 | Volume: 127 | Issue: 2 | Pages: 306-311

10.1152/japplphysiol.00798.2018 | PMID 31194601 Get It

This paper reports temporal changes in physiological measurements of exercise performance in a young man transitioning from alpine skiing until he became a world junior champion time trial cyclist after only 3 yr of bike-specific training. At the time he became World Champion he also achieved among the highest reported maximal oxygen uptake (V̇o2max) value, 96.7 ml·min−1·kg−1, or 7,397 ml/min in absolute terms at 76.5 kg, which had increased by 29.6% from 74.6 ml·min−1·kg−1 pre-bike-specific training. After 15 mo with almost no structured exercise training, V̇o2max returned to 77.0 mL·min−1·kg−1 and was similar to the value reported before specific bike training, albeit with absolute term (6,205 ml/min) still being 11.3% higher. Part of the explanation for his athletic achievements is likely also related to the up to 20.9% improvement in Power@4 mmol/l (W). Although genetic profiles of endurance athletes have not generated data suggesting a shared genetic signature associated with elite endurance performance, this case study highlights the importance of intrinsic biological factors in elite endurance performance. NEW & NOTEWORTHY This study shows that very high V̇o2max values (>70 ml·min−1·kg−1) can be found in individuals not previously specializing in aerobic training and that values of >90 ml·min−1·kg−1, as well as a cycling world junior champion title, can be achieved in such individuals with just 3 yr of dedicated exercise training.
Applying Time and Motion Methodology to Calculate Program Coordinator FTE
Bowler, Carrie , Pritt, Bobbi S. , Pritt, Bobbi, Pritt, Bobbi S

Mayo Clinic

Journal of Graduate Medical Education | June 13, 2019 | Volume: 11 | Issue: 3 | Pages: 349-350

10.4300/jgme-d-18-00901.1 | PMID 31210878 Get It

Detection of Naegleria fowleri, Acanthamoeba spp, and Balamuthia mandrillaris in Formalin-Fixed, Paraffin-Embedded Tissues by Real-Time Multiplex Polymerase Chain Reaction
Norgan, Andrew P. , Sloan, Lynne M., Pritt, Bobbi S. , Pritt, Bobbi S , Norgan, Andrew P

Mayo Clinic

American Journal of Clinical Pathology | June 13, 2019 | Volume: 152 | Issue: 6 | Pages: 799-807

10.1093/ajcp/aqz103 | PMID 31415080 Get It

Abstract Objectives Pathogenic free-living amebae (FLAs) cause skin, ocular, and central nervous system (CNS) infections with significant morbidity and mortality. Diagnosis of FLA infections by pathologic examination of tissue sections can be aided using molecular assays. This study investigated the performance characteristics of a multiplex real-time polymerase chain reaction (PCR) assay (FLA-PCR) for detection and differentiation of FLAs in clinical specimens. Methods FLA-PCR was performed on 39 human specimens comprising one cutaneous, 14 corneal, and 24 CNS formalin-fixed, paraffin-embedded (FFPE) tissues with a histopathologic diagnosis of FLA infection and four CNS FFPE tissues with inflammation but no evidence of FLAs. In addition, clinical specificity and assay limit of detection were determined. Results FLA detection sensitivities ranged from 79% to 84% in FFPE tissues. No cross-reactivity was observed. Conclusions While sensitivity is limited, FLA-PCR assay may serve as a useful adjunct for detection or confirmation of FLA infections in FFPE tissues.
FP087DISTINCT GENE EXPRESSION PATTERNS IN EXPERIMENTAL RENAL ARTERY STENOSIS AND ISCHEMIA-REPERFUSION INJURY
Osman, Mazen, Aberger, Simon , Li, Andrea, Taha, Hula, Osman, A. A., Grande, Joseph P. , Li, Andrea, Taha, Hula, Osman, Adam

Mayo Clinic

Nephrology Dialysis Transplantation | June 13, 2019 | Volume: 34 | Issue: Supplement_1 | Pages: No page available

10.1093/ndt/gfz106.fp087 Get It